Tomorrow the German KWS Saat will publish her past quarter's figures. Based on the analysts' consensus: both the revenue and the net result would be the highest in years. Over the current book year the total revenue will be 1,15 billion euros (consensus estimates). The expected revenue would be a record for the company. This is slightly more than 2016's revenue of 1,08 billion euros.
The analysts anticipate for 2017 a record net profit a 105 million euros. The majority of the analysts expects for this year a profit per share of 15,83 euros. Based on this the price/earnings-ratio is 21,85.
For this year the analysts expect a dividend of 3,42 euros per share. The dividend yield is then 0,99 percent. The average dividend yield of the biotech companies equals a limited 0,06 percent.
ValueSpectrum.com News Wire & Equity Research: +31 084-0032-842
Copyright analist.nl B.V.
All rights reserved. Any redistribution, duplication or archiving prohibited. analist.nl doesn't warrant the accuracy of any News Content provided and shall not be liable for any errors, inaccuracies or for any actions taken in reliance thereon.